What is the dosing of 3% hypertonic saline solution to increase sodium levels in patients with hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended dosing for 3% hypertonic saline to increase serum sodium is typically 1-2 mL/kg given intravenously over 10-20 minutes, which can be repeated if needed, with a goal to raise sodium by up to 5 mmol/L in the first hour and a limit of 8–10 mmol/L every 24 hours thereafter until the serum sodium concentration reaches 130 mmol/L, as suggested by the most recent guidelines 1.

Key Considerations

  • The use of 3% hypertonic saline is reserved for patients with severely symptomatic acute hyponatremia, especially if a transplant is imminent, due to the risk of worsening fluid overload 1.
  • It is crucial to avoid correcting sodium too rapidly to prevent osmotic demyelination syndrome, a serious neurological complication, with a recommended increase of no more than 8-10 mEq/L in the first 24 hours 1.
  • Continuous infusion can be used at rates of 0.5-2 mL/kg/hour, with frequent monitoring of serum sodium levels (every 2-4 hours initially) to ensure safe and effective correction of hyponatremia.
  • The treatment should be administered in a monitored setting with regular electrolyte checks and should be slowed or stopped once symptoms improve or target sodium levels are reached.

Mechanism and Monitoring

  • The mechanism of action of 3% hypertonic saline involves creating an osmotic gradient that pulls water from intracellular to extracellular spaces, thereby increasing serum sodium concentration and reducing cerebral edema.
  • Frequent monitoring of serum sodium levels is essential to avoid overcorrection and to adjust the treatment regimen as needed, with a focus on preventing complications such as osmotic demyelination syndrome 1.

From the Research

Dosing of 3% Hypertonic Saline Solution

  • The dosing of 3% hypertonic saline solution to increase sodium levels in patients with hyponatremia is typically administered as a 100- to 150-ml intravenous bolus or continuous infusion 2.
  • For symptomatic hyponatremia, rapid correction is usually obtained by hypertonic saline (3%) infusion 3.
  • A 4- to 6-mmol/L increase in serum sodium concentration is adequate in the most seriously ill patients and this is best achieved with bolus infusions of 3% saline 4.
  • The European guidelines recommend bolus-wise administration of 150 mL of 3% hypertonic saline for the treatment of symptomatic hyponatremia 5.

Correction Rates

  • The treatment target is defined as an increase in serum sodium by 5-10 mEq/L within the first 24 h and a maximum of 8 mEq/L during subsequent 24 h 5.
  • Appropriate therapy should keep the patient safe from serious complications of hyponatremia while staying well clear of correction rates that risk iatrogenic injury, with suggested therapeutic goals of 6 to 8 mmol/L in 24 hours, 12 to 14 mmol/L in 48 hours, and 14 to 16 mmol/L in 72 hours 4.
  • Overcorrection of hyponatremia (defined as 10 mmol/L in 24 hours, 18 mmol/L in 48 hours, and 20 mmol/L in 72 hours) risks iatrogenic brain damage 4.

Administration and Monitoring

  • Frequent monitoring of the serum sodium concentration and urine output are mandatory 4.
  • Administration of desmopressin to terminate an unwanted water diuresis is an effective strategy to avoid or reverse overcorrection 4.
  • Reducing bolus-volume and reevaluation before repeating bolus infusion might prevent overcorrection, especially in severely symptomatic patients 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Research

The treatment of hyponatremia.

Seminars in nephrology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.